Matthew MY Lee
@matthewmylee
Followers
212
Following
299
Statuses
105
Cardiology Clinical Senior Lecturer @UoGHeartFailure BHF ICAMS University of Glasgow
Joined June 2009
⚖️Direct tissue vs wt loss effects—both matter, but how much?🤔 💉#GLP1RA in #Obesity & chronic conditions: 🩸#T2DM📈#HTN🏥#MACE❤️#HFpEF 🫘#CKD⚠️#MASH💤#OSA🦴#OA 🔗 Grateful to Naveed Sattar🙏 #CardioTwitter @TheLancetEndo @MetaMedTeam @UofGSCMH @UofGMVLS
0
3
10
0
112
0
RT @EJHFEiC: 🗞️ SUGAR-DM-HF #CMR estimated PCWP & congestion markers, and effect of #empagliflozin in #HFrEF with dysglycaemia @ESC_Journ…
0
14
0
What’s new in #HF Dec 2024? #GDMT in ESC HF III Registry #HFimpEF predictors LV vol & exe capacity in #HFpEF HFpEF in repaired #Coarctation Aorta #CMR #DCMmrEF risk stratificatn #Chagas cardiomyopathy @PauCodi @DaniTomasoni @AlbertoAimo90 @ESC_Journals
1
9
21
EMPRESS-MI: Empagliflozin vs placebo, n=105 w/ LVSD (mean LVEF 34.8%) post-AMI (24wks): ↔️LVESVI, LVEDVI, LVEF, LAVI, LVMI ↔️NT-proBNP, hs-TnI ↗️Hct ↘️urate, weight 🔗 @CarberryJaclyn @Kieranfdocherty
@markcpetrie20 @ColinBerryMD
@UoGHeartFailure @UofGSCMH
0
11
24
RT @drbennisahmed: Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRES…
0
5
0
RT @JACCJournals: Ready for #aficamten, a next-in-class myosin inhibitor for oHCM? See the results: #JACC #cvHCM #…
0
26
0
RT @CVCTForum: #CVCT2024 : NEW ! Submit your abstract for POSTER PRESENTATIONS → A special French “Wine & Cheese Poster Viewing Session” wi…
0
5
0
RT @jo_osmanska: Our latest paper summarising evidence for subcutaneous furosemide in heart failure.
0
10
0
RT @JACCJournals: #HFSA2024 #JACC LBCT SimPub: This analysis of SEQUIOA-HCM demonstrated that #aficamten was assoc w/ broad clinical effica…
0
16
0
What’s new in #HF Oct 2024? #Finerenone #FINEARTS-HF #FINE-HEART #Semaglutide #STEP-#HFpEF #SELECT #FLOW
#MitraClip #RESHAPE-HF2 #MATTERHORN
#Vutrisiran #HELIOS-B #Aficamten #SEQUOIA-#HCM #FOREST-HCM @PauCodi @DaniTomasoni_ @AlbertoAimo90 @ESC_Journals
0
6
12
RT @ZHeart11768530: 🔴What's new in heart failure? October 2024⤵️ #openaccess 🔹 #Cardiology #FOAMed #MedEd #medst…
0
31
0
RT @MasriAhmadMD: An informative editorial by @MKIttlesonMD summarizing the background, context and findings from 4 studies in @JACCJournal…
0
18
0
RT @MasriAhmadMD: Another important analysis from #SEQUOIA-#HCM (#Aficamten vs #placebo) in patients with obstructive HCM This is aficamte…
0
4
0
RT @Kieranfdocherty: Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in HFmrEF/HFpEF: a Prespecified Analysis of Th…
0
22
0
RT @NEJM: Original Article: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF)
0
49
0
RT @MasriAhmadMD: Now in @JAMACardio , a detailed #CPET analysis from the #SEQUOIA #HCM trial led by Matt Lee and @GLewisCardiol Introduc…
0
1
0
RT @GLewisCardiol: Published today in @JAMACardio. Cardiopulmonary Exercise Testing (#CPET) in clinical trials captures ∆es in ex. performa…
0
17
0